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Vertebrates have co-evolved with microorganisms resulting in a symbiotic relationship,
which plays an important role in health and disease. Skin and mucosal surfaces are colo-
nized with a diverse population of commensal microbiota, over 1000 species, outnumbering
the host cells by 10-fold. In the past 40 years, studies have built on the idea that commen-
sal microbiota is in constant contact with the host immune system and thus influence
immune function. Recent studies, focusing on mutualism in the gut, have shown that
commensal microbiota seems to play a critical role in the development and homeosta-
sis of the host immune system. In particular, the gut microbiota appears to direct the
organization and maturation of lymphoid tissues and acts both locally and systemically to
regulate the recruitment, differentiation, and function of innate and adaptive immune cells.
While the pace of research in the area of the mucosal–immune interface has certainly
intensified over the last 10 years, we are still in the early days of this field. Illuminating the
mechanisms of how gut microbes shape host immunity will enhance our understanding
of the causes of immune-mediated pathologies and improve the design of next-generation
vaccines. This review discusses the recent advances in this field, focusing on the close
relationship between the adaptive immune system and commensal microbiota, a constant
and abundant source of foreign antigens.
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INTRODUCTION
Microorganisms represent the oldest and most ubiquitous forms
of life on our planet. These microbes evolved alongside other
organisms, like metazoans, with a portion of them colonizing and
establishing life-long relationships with larger species. Such mutu-
alistic relationships have been described in plants (1), insects (2),
worms (3, 4), fish (5, 6), birds (6), and mammals (7). Shortly after
birth, the mammalian mucosal tissues are exposed to the envi-
ronment and colonized by viruses, bacteria, protozoa, and fungi,
resulting in the formation of complex populations of microbes,
collectively called the commensal microbiota. The mammalian
commensal microbiota constitutes of over 1000 different species
of microbes and outnumbers the host cells by 10-fold (8, 9).
The intestinal mucosa harbors the largest amount of microbes in
the human body; many are beneficial while some, termed patho-
bionts, are generally harmless, but can turn pathogenic with an
imbalance of the microbial community. The commensal micro-
biota has long been appreciated for its essential contributions to
host development and health. Such benefits include metabolism
of indigestible food byproducts, generation of nutrients, defense
against pathobionts, promotion of angiogenesis and enteric nerve
function, maintenance of intestinal structure, and contribution
to the development and regulation of the mammalian immune
system (10–15).
For better and for worse, the mammalian immune system is one
aspect of host physiology that is heavily influenced by commen-
sal microbiota. Both human and animal model research supports
the hypothesis that immune-related disorders like inflammatory
bowel disease (IBD) (16), cancer (17), diabetes (18, 19), aller-
gies (20), and even obesity (21, 22) may result from dysbiosis
of the commensal microbial communities. To better understand
how microbiota contributes to the onset and/or exacerbation of
such disorders (23, 24), it is important to understand how signals
from intestinal microbiota influence the immune system under
normal and diseased conditions. This review discusses the effect
of gut microbiota on the mammalian immune system, with a par-
ticular focus on T cell differentiation, responses, and homeostasis.
First, we discuss how the host senses microbes. Then, we review
the ability of dendritic cells (DCs) to induce immunogenic or
tolerogenic responses to microbial signals. Finally, we examine the
signals that microbes provide and their role in modulating T cell
differentiation and function.
HOST SENSING OF MICROBES
Commensal microbiota may be largely harmless but it is neverthe-
less crucial to maintain barriers to prevent opportunistic invasions
and, occasionally, an immune response is required to keep poten-
tial pathobionts in check. In mucosal tissues, such a response is
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promoted by both epithelial and innate immune cells via liga-
tion of various receptors expressed differentially in these cells. The
recognition of microbial particles such as DNA, cell wall com-
ponents, and metabolites occurs in the context of innate toll-like
receptors (TLRs), NOD-like receptors (NLRs), G protein-coupled
receptors (GPCRs), other pattern-recognition receptors (C-type
lectin receptors, RIG-I-like receptors, and AIM-2-like receptors),
and yet to be identified receptors expressed by both hematopoi-
etic and non-hematopoietic lineage cells in mucosal tissues. The
following section will focus on the use of TLRs and NLRs by the
host to sense microbes.
TOLL-LIKE RECEPTORS
Toll-like receptors are pattern-recognition receptors, which bind to
evolutionarily conserved molecules expressed by bacteria, viruses,
and other microorganisms (25). Some of them (TLRs 2, 3, 4, and
5) are expressed on the cell surface, whereas others (TLRs 3, 7,
and 9) are expressed in endosomal compartments of cells (26, 27).
TLRs are expressed in high levels on epithelial cells and innate
immune cells and can sense various microbial molecules such
as double- and single-stranded RNA, LPS, flagellin, CpG (28),
ensuring detection of all microbes.
Toll-like receptor ligands have been implicated in the onset
and management of various diseases. For instance, TLR signaling
has been shown to affect Crohn’s disease and psoriatic arthritis in
humans (29, 30). Studies from the non-obese diabetic (NOD)
murine model of type-1 diabetes have also revealed that dis-
ruption of TLR signaling protects these mice from developing
diabetes (31). These data indicate that microbial recognition via
TLRs has a significant implication in the onset of autoimmune
and inflammatory diseases.
Toll-like receptor ligands have also been suggested to modulate
mucosal cell function and tissue maintenance. One mechanism
is by inducing the synthesis of antimicrobial peptides and tissue-
repair factors by intestinal epithelial cells (IECs) (32). Moreover,
LPS-induced TLR signaling has been linked to NFκB activation
of IECs, which results in promoting either a tolerogenic or a pro-
inflammatory environment depending on the microbial context
(33). LPS also acts directly on mucosal DCs, affecting their acti-
vation and migration to various anatomical sites where they can
induce adaptive responses (33). Similar to IECs, TLR signals can
induce either activation or tolerance programs in DCs (discussed
below).
NOD-LIKE RECEPTORS
NOD-like receptors contain multiple subfamilies and are
expressed by many organisms from plants to mammals. Mam-
malian NLRs play a crucial role in sensing microbes and induc-
ing various pro-inflammatory programs in response to micro-
bial products (34). NLRs are not only essential in responses to
pathogens but they are also necessary for the development of
intestinal lymphoid tissues, maintenance of commensal commu-
nities, and mounting antigen-specific immune responses (35).
This section will discuss only the NLRC and NLRP subfamilies
of NLR signaling. For a more comprehensive discussion of NLRs,
see the recent review by Chen et al. (36).
The NLRC subfamily contains NOD1, which recognizes
peptidoglycan-containing mesodiaminopimelic acid (iE-DAP),
and NOD2, which recognizes muramyl dipeptide (MDP) (37).
One of the major functions of NOD1/2 is the activation of NFκB
signaling. Pathogen induction of NOD2 results in NFκB activa-
tion and secretion of pro-inflammatory cytokines, especially IL-1
(34). Mutations in NOD2 are linked to Crohn’s disease; here, the
inability to induce NFκB signaling on IECs and immune cells is
thought to impair intestinal mucosal barrier function, resulting
in pathologies from invasion of the intestine by commensal bac-
teria (38). Support for this notion was obtained from work in
the mouse. Hence, increased intestinal permeability to commen-
sal bacteria was reported in NOD2 deficient mice, indicating that
NOD2 signaling is important for maintaining intestinal epithe-
lial integrity and barrier function (39). Similarly, NOD1 also has
a role in maintaining intestinal homeostasis but in other related
ways. Thus, NOD1 deficient mice possess a decreased number of
intestinal lymphoid follicles and lower expression of CCL20 as well
as a change in microbiota composition (35). NOD1 and 2 signaling
has been implicated in both pro-inflammatory and immunoreg-
ulatory roles as it can induce secretion of IFN-γ, IL-12, IL-6 but
also of IL-10 in various models of disease, demonstrating thus sug-
gesting that a fine balance of NLRC signaling must be maintained
(40–43). It is clear that NOD1 and NOD2 contribute to regulatory
and inflammatory responses to microbes but it is the integration
of these signals and those from other receptors, such as NLRP, that
likely result in determining whether a regulatory or inflammatory
response is appropriate.
NLRP and NLRC signaling are closely associated with the
immune system as they affect inflammasome function. The
inflammasome is a multiprotein complex that is required for the
enzymatic processing of pro-forms of IL-1β and IL-18. Multi-
ple NLRs can activate the inflammasome but they all recognize
bacterial flagellin or type III secretion system (44). It has been
suggested that NLRP and NLRC signaling is more specific than
NOD1/2 signaling since it is triggered not only by these two
types of bacterial molecules but it also has regulatory molecules
in place that are recruited only by certain species of bacteria
that merit an inflammatory response (44, 45). A recent model
proposes that inflammasome activation to various microbes is
mediated commonly by NLRC4, but the specificity comes from
differential NLRP recognition of products from specific bacterial
species (46). NLRP4, NLRP3, and NLRP1 have been associated
with induction of the inflammasome in response to bacterial, fun-
gal, and viral products; mutations in these genes are associated
with higher susceptibility to bacterial and viral infections as well
as autoimmunity (47–49).
Even though NLRP activation of the inflammasome was
believed to be largely in response to infection and severe cellu-
lar stress, it was recently demonstrated that NLRP6 plays a crucial
role in regulating interactions with commensal microbiota dur-
ing steady-state conditions. NLRP6 knockout animals were highly
susceptible to DSS-induced colitis and had decreased intestinal
IL-18 levels as well as altered microbiota composition (50). It is
unclear exactly what triggers NLRP6-mediated activation of the
inflammasome but it likely occurs in response to a collection
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of environmental signals. Because NLRP activation can occur in
the context of microbiota, stress, or infection, the discrimination
between pathogenic and commensal microbes likely involves the
integration of multiple signals from the inflammasome, NFκB
signaling, and other pathways by innate immune cells.
INNATE LYMPHOID CELLS
Innate lymphoid cells (ILCs) comprise a recently described popu-
lation of innate immune cells, which have been shown to regulate
immunity, inflammation, and tissue repair in various anatomical
sites (51–53). Like B and T cells, they differentiate from a com-
mon lymphoid progenitor but, unlike B and T cells, they lack a
rearranged antigen-specific receptor (51–53). Nonetheless, ILCs
closely resemble CD4 helper T cells and express many of their
transcription factors and molecules. Multiple subsets of ILCs exist,
and they are classified into three groups – Groups 1, 2, and 3 –
according to the expression of distinct transcription factors and
effector molecules (51–53). Group 1 ILCs, such as NK cells, are
characterized by the expression of the transcription factors T-bet
and/or Eomesodermin and the production of the cytokine IFN-γ
in response to stimulation with IL-12 and IL-18 (51–53). Group
2 ILCs’ canonical features are the expression of the transcription
factors RORα and GATA3 and the expression of IL-5 and IL-13
in response to stimulation with IL-25, IL-33, and TLSP (51–53).
Finally, group 3 ILCs, such as lymphoid tissue inducer (LTI) cells,
NKp46+, and NKp46− cells, are characterized by the expression of
RORγt and/or T-bet and/or the aryl hydrocarbon receptor (AHR)
and upon stimulation with IL-23 and IL-1β, they produce IL-22
and/or IL-17 and/or IFN-γ (51–53).
Innate lymphoid cells inhabit various tissues where they have
been shown to direct inflammation at mucosal surfaces, especially
in a response to infection, and confer resistance to pathogens (54).
Group 1 ILCs include NK cells and a population of human mucosal
ILCs, which lack expression of NK surface markers but produce
high levels of IFN-γ in response to IL-18 and IL-12 stimulation
(55). They are present in high levels in patients with Crohn’s
disease and contribute to increased inflammation in the intes-
tine (56). A new NKp44+CD103+ population of ILC1s, which
produces large amounts of IFN-γ, CCL4, and TNFα, has been
recently described in the human intestine (57), and it has been
suggested that it is the innate counterpart of tissue-resident mem-
ory CD8 T cells. Group 2 ILCs participate in protection against
helminth infection in the intestine by producing IL-25 (58–60)
as well as in wound healing in the airways via the production
of amphiregulin, which induces epithelial cell proliferation (61,
62). Group 3 ILCs have been shown to regulate CD4 T cell
responses to commensal bacteria in the intestine of mice as well
as to prevent bacterial dispersal to peripheral tissues (63, 64).
Recently, it has also been revealed that intestinal macrophages
act through ILC3 to induce the production of tolerogenic mol-
ecules (IL-10 and retinoic acid) by intestinal DCs or macrophages
and thus promote the induction and homeostasis of regulatory T
cells in the intestine and the mesenteric lymph nodes (65). Even
though ILCs are a novel population of innate immune cells, it
has been well demonstrated that they play a key role in mucosal
defense from pathogens as well as in maintenance of mucosal
tissues.
DENDRITIC CELL FUNCTION DEPENDS ON LOCATION AND
ENVIRONMENT
Mucosal DCs are in constant contact with commensal microbiota
via various pattern-recognition receptors. Because DCs have the
unique ability to elicit a robust T cell response (66), they are dif-
ferentially conditioned based on anatomical location and local
antigenic load to be either tolerogenic or pro-inflammatory in
response to the same signal. In the lungs, TLR4 signaling on DCs
results in antigen-specific CD4 T cell mediated inflammation (67).
On the contrary, TLR4 signaling in intestinal DCs is shown to be
tolerogenic (68), suggesting that the environmental cues and loca-
tion determine how a DC integrates such signals. In the context of
other TLR ligands, administration of CpG in TLR4 deficient mice
reduces their susceptibility to systemic allergy development, argu-
ing for a tolerogenic role of TLR9 signaling (69). In contrast, when
CpG is administered to germ-free mice, it causes increased IFN-γ
and IL-17 production in the intestine of these mice, conferring
protection against intestinal parasites, indicating a more activating
role for TLR9 (69). Based on these data, it is widely accepted that
the environmental context in which DCs integrate the same signal
determines whether an inflammatory immune response occurs.
At mucosal sites, unlike in other lymphoid tissues, DCs per-
form unique roles and occupy distinct niches (70). In addition
to specifying the inflammatory or anti-inflammatory nature of
the T cell response, DCs also direct the homing of effector cells.
In the mesenteric lymph node, they can promote upregulation
of CCR9 and α4β7 on B and T cells (71, 72), thereby facilitat-
ing their migration back to the intestine (73, 74). In the intestine,
DCs translocate to and reside in the lamina propria (LP), Peyer’s
patches, isolated lymphoid follicles, and mesenteric lymph node,
where they sample and present luminal and self antigens to T cells
(75). In the Peyer’s patches, DCs are divided into three groups:
CXCR1+ DCs, CCR6+ DCs, and CCR7+ DCs. Each group has
distinct functions and characteristics. CXCR1+ DCs are found in
the Peyer’s patch in close proximity to M cells, positioned there
with the purpose to sample luminal antigens in a TLR-dependent
manner (76). CCR6+ DCs are migratory and are found in the
dome of the Peyer’s patches, from where they readily translocate
to the follicle-associated epithelium in response to microbial stim-
ulation. Finally, CCR7+ DCs are found in the T cell areas of the
Peyer’s patches, where they can induce T cell activation (77, 78)
and migration (73, 74), and IgA production by B cells (79, 80) in
response to microbial signals (81).
As Peyer’s patches are rare along the intestinal tract, the major-
ity of gut-associated DCs are more frequently found in the LP
of the small intestine. LP DCs, often differentiated from cir-
culating precursors (82), express tight junction proteins that
allow them to reach their dendrites between IECs and sample
the luminal contents directly (83). This phenomenon depends
on CX3C chemokines and TLR ligation (84, 85). CX3CR1
deficient mice exhibit impaired luminal sampling by DCs and
are thus more susceptible to Salmonela typhimurium infection
(85). This finding suggests that luminal sampling by DCs may
be critical for protective immune responses against intestinal
pathogens.
As mentioned above, intestinal DCs are thought to be more
tolerogenic than systemic DCs (86, 87). It has been shown that
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stimulation of intestinal DCs with LPS results in elevated IL-10
secretion, whereas the same stimulation of circulating DCs results
in the production of a variety of pro-inflammatory cytokines (88,
89). The mechanisms that condition intestinal DCs to produce
IL-10 in response to LPS stimulation, but not systemic DCs, are
still largely unknown. It has been suggested that reduced TLR
expression (88, 89) and hyporesponsiveness to TLR ligation (68)
as well as negative regulation of NFκB pathways via NOD2 signal-
ing play a role in the desensitization of intestinal DCs to microbial
antigens (40–43).
Dendritic cells play a key role in promoting T cell differentia-
tion and responses to microbiota in the gut as well as systemically.
Some studies have shown that intestinal DCs can transport self
and microbial antigens to the mesenteric lymph nodes (90) where
they orchestrate T cell activation and differentiation into effec-
tor cells. Intestinal DCs are not exclusively tolerogenic and can
induce pro-inflammatory T cell responses by secreting IL-12 and
IL-23. IL-12 is a master inducer of T helper 1 (Th1) responses
(91) and thus plays an important role in Th1-associated autoim-
mune diseases, such as IBD (92–94). IL-23 has been implicated
in inflammatory T helper 17 (Th17) responses (95) in murine
models of joint (96) and intestinal inflammation (97–100) as well
as psoriasis (101, 102). Conversely, in addition to Th1 and Th17
responses, intestinal DCs can induce T regulatory cells in the con-
text of retinoic acid, TGF-β, and IL-10 in the gut, suggesting that
intestinal DCs can serve to direct T cell differentiation so as to
induce the appropriate response based on different contexts (75,
86, 87). DCs can sense microbial antigens from commensal and
pathogenic microbes and ideally are able to differentiate between
the two in order to induce appropriate T cell responses, protecting
the host from infection but at the same time creating a tolerogenic
environment for the commensal microbiota to thrive.
COMMENSAL MICROBIOTA MAINTAINS T CELLS’ POISED
STATE
Many dramatic effects of commensal microbiota on host T
cells have been documented. Following microbial colonization,
immune cells are recruited, induced to differentiate and to reside in
the gut (13). At steady state, the intestine houses a large number of
T cells, which produce IL-17, IL-22, IFN-γ, and IL-10 (69, 103). In
the absence of microbiota, there are deficiencies in the production
of these cytokines (15, 103), indicating that commensal microbes
control their constitutive production in the gut. CD4 T cell num-
bers have been shown to be decreased in germ-free mice, affecting
T helper 1 (Th1) and T helper 17 (Th17) cells, although regula-
tory T cell (Treg) frequencies remain the same (69, 103). When
germ-free mice are conventionalized, a broad Th1, Th17, and Treg
expansion occurs and cytokine production is recovered in the gut,
indicating that the accumulation of functional CD4 T cells in the
gut is microbiota dependent (104). Furthermore, upon infection
with a mucosal pathogen, CD4 T cells in the intestine respond to
both the pathogen as well as to the commensal microbiota that
permeate the intestinal epithelial layer, demonstrating the ability
of the adaptive immune system to overcome its tolerance to com-
mensals and its ability to contain pathobionts and opportunistic
pathogens (105). Among the CD8 T cell populations in the gut,
intraepithelial lymphocytes (IELs) are significantly decreased in
germ-free mice, and they are restored upon colonization (106).
Because the host needs metabolites and essential nutrients from
microbes, yet at the same time it must protect itself from infection,
maintaining a balance between pro- and anti-inflammatory T cell
populations in the gut is essential.
In addition to affecting the local populations, there is evidence
supporting the notion that commensal microbes also influence the
generation and function of the host immune system more broadly.
Peripheral lymphoid organ structure and function are disrupted
in the absence of commensal microbiota (107). Moreover, T cell
responses to systemic antigens are also altered in the absence of
commensal microbiota. Recent studies have suggested that com-
mensal microbiota keeps the immune system primed and ready
to respond during the steady state and conventional mice respond
more robustly to infection than germ-free mice (108). This section
will discuss the effect of commensal microbiota on T cell responses
both at mucosal sites and systemically.
TH17 CELLS
IL-17 producing Th17 cells are represented in high numbers in
the LP of the small intestine, where they play a role in protec-
tion against extracellular pathogens (103). The differentiation of
Th17 cells is dependent on their expression of the transcription
factor RORγt, and it is driven by signals from TGF-β and IL-21 or
IL-6 (109). Additionally, Th17 cells require IL-23 for maturation
and survival (110). As the number of Th17 cells is dramatically
decreased in the small intestine of germ-free animals, there is
a widely accepted notion that commensal bacteria are required
to cue Th17 differentiation (103). A TLR-independent mecha-
nism for the promotion of Th17 differentiation in the gut has
been suggested, as signals through MyD88 are not necessary for
the induction of Th17 cells (103). Furthermore, data from mice
mono-associated with segmented filamentous bacteria (SFB) indi-
cate that even a single species of commensal bacteria is enough to
direct T cell differentiation toward a Th17 bias (104, 111).
Not only do microbiota-derived signals stimulate the differ-
entiation and accumulation of Th17 cells in the intestinal LP,
but they also maintain Th17 cell homeostasis and survival. Stud-
ies have indicated that treatment with the antibiotic vancomycin
decreases Th17 populations in the small intestine of conventional
mice (103, 112), whereas treatment with a complex cocktail of
antibiotics, results in a decreased Th17 frequency in the mesen-
teric lymph node (113). In other mucosal sites, such as the skin,
resident commensal microbiota have been shown to induce Th17
and Th1 differentiation to protect the host from pathogens and
possible opportunistic microbes (114).
REGULATORY T CELLS
Maintaining tolerance to resident bacteria is the key to preventing
inflammatory diseases in mucosal tissues. Before the importance
of tolerance was widely accepted, it was commonly believed that an
unknown pathogen was the trigger for IBD. However, successful
treatment of the disease with immunosuppressive drugs has lead
to the hypothesis that IBD may result from defects in tolerance to
otherwise non-pathogenic gut commensals (115–118).
The idea that T cells must be tolerized to commensal micro-
biota was suggested decades ago, when in an adoptive transfer
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model, naïve CD4 T cells caused colitis (119) but were held in
check by another population of CD4 T cells (118), now known as
regulatory T cells (Tregs). For the purposes of this review, Tregs
are T cells that express the master regulator transcription factor,
Foxp3, and display anti-inflammatory activity, including secretion
of TGF-β and/or IL-10 (120). Extrapolation from early studies
led to the proposal that regulatory T cells are required to prevent
aberrant T cell responses to resident microbes. Scientists were thus
surprised when data from the small intestine of germ-free mice
emerged to show that commensal bacteria are not necessary for
the development of Tregs in that organ (121–123). Furthermore,
when germ-free Tregs were assayed, they were able to suppress
colitis-like symptoms albeit not as well as conventional Tregs in
the adoptive transfer model of the disease (122, 124), indicat-
ing that functionally and developmentally, small intestinal Tregs
are independent of commensal microbiota. Even though the small
intestine houses a large amount of T cells, it is the colon that houses
the largest load of microbiota and is the site of colitis observed in
these experiments.
Recent studies on the effect of gut microbiota on Treg develop-
ment and function have elucidated that colonic Tregs are signifi-
cantly decreased in germ-free mice, indicating that, in the colon,
commensal microbiota is the major inducer of colonic Tregs (125,
126). The exact mechanism of how the induction of colonic Tregs
occurs remains unknown. It has been suggested that certain species
of microbiota, such as Clostridium clusters IV and XIVa, can
induce Foxp3+ Treg generation in the colon (125). In order to
determine whether commensal microbiota is required for the dif-
ferentiation of naïve peripheral T cells into colonic Tregs, several
groups looked at the expression of an Ikaros-family transcription
factor, Helios, which is thought to signify thymic origin of Tregs.
They showed that in the colons of germ-free mice, most of the
Tregs were Helioshi, suggesting that these T cells became Tregs in
the thymus (so-called thymic or tTreg), whereas their counterparts
in conventional mice were mostly Helioslo, indicating that these
CD4 T cells converted to Tregs in the peripheral tissues (so-called
peripheral or pTreg) (125, 127). These results suggested that in
conventional hosts, colonic Tregs are differentiated outside of the
thymus (presumably in the gut) in response to foreign antigens.
Because the use of Helios in the field is still quite controversial
(128, 129), other experimental approaches were utilized to con-
firm the importance of commensal microbiota on colonic Treg
differentiation and function. Subsequent work using Neuropilin-
1 (Nrp-1) as a marker to detect tTregs confirmed that induction of
pTregs in the colon was mediated by commensal microbiota (130).
Another study using a fixed TCRβ showed that colonic Tregs uti-
lize different TCRs from systemic circulating Tregs, reaffirming the
notion that they recognize distinct gut antigens (127). Addition-
ally, TCRs from colonic Tregs, expressed as transgenes, were unable
to induce generation of tTregs, again supporting the notion that
colonic Tregs were peripherally induced in response to commensal
antigens (127).
As the mechanism is still unknown, multiple models have been
offered to explain how microbiota supports an abundance of
pTregs in the gut. It has been proposed that preferential expansion
of pTregs occurs in the intestine either by microbial components
influencing pTregs directly or indirectly through the products
of bacterial metabolism, such as short-chain fatty acids (131–
133), and from presentation of bacterial peptides (such as PSA)
by innate immune cells (134–136) and/or from effector T cells
(129, 137, 138). Another hypothesis offers that the foreign anti-
gen load in the gut is so large that, given a limited capacity for
antigen presentation, self-peptides are displaced and the increased
prevalence of pTregs simply reflects the increased density of their
targets (i.e., foreign-peptide/MHC-II) and decreased availability
of tTreg targets (i.e., self-peptide/MHC-II) (127). The question
of the specificity of small intestinal pTregs still remains open. It is
possible that these Tregs are generated in response to self or dietary
antigens, as the abundance of these antigens is greater in the small
intestine than in the colon.
Fostering a balance between tolerating commensal microbiota
and maintaining the ability to mount an immune response to
microbial pathogens is crucial for the survival of the host. Despite
the seeming bias toward induction of tolerogenic responses in the
gut, immune responses still occur readily against pathogens to pro-
tect the host from infections. The mechanisms utilized by the host
to distinguish between the commensal and pathogenic bacteria are
still poorly understood and are under intense investigation.
INTRAEPITHELIAL LYMPHOCYTES
Because the intestinal mucosa harbors various opportunistic bac-
teria, the host has evolved the ability to house cytotoxic killer T
cells in close proximity to potential sites of pathogen entry, like
the intraepithelial layer of the intestine. The lymphocytes that
reside there, also known as IELs, are composed of CD8 T cells that
are recruited to and remain in that compartment for the dura-
tion of the host’s life. There are three types of IELs, each bearing
different characteristics and functions: αβ TCR CD8αα, αβ TCR
CD8αβ T cells, and γδ TCR T cells. Whereas αβ TCR IELs respond
mainly to pathogenic challenge of the epithelial mucosa, γδ TCR
IELs participate in would healing and tissue repair by produc-
ing pro-inflammatory cytokines and chemokines and recruiting
neutrophils, eosinophils, and T cells.
αβ TCR IEL differentiation and maintenance depend on TLR
recognition of bacterial signals as MyD88 deficient and germ-free
mice exhibit diminished numbers of these cells (139–141). Func-
tionally, in germ-free and antibiotic-treated mice, the cytotoxic
activity of αβ TCR IELs is significantly decreased when compared
to conventional mice (140), a phenotype that can be rescued by
supplying exogenous endotoxin. This suggests that αβ TCR IEL
function is both induced and maintained by ubiquitous bacterial
components (139, 142).
Similarly, recent data have elucidated the dynamic relation-
ship between commensal bacteria and γδ IELs during mucosal
injury. γδ TCR IELs restrict the spread of bacteria to the mesen-
teric lymph node following intestinal injury as shown by the lack
of such a response in γδ TCR IEL-deficient mice (143). γδ TCR
IELs exhibit their functions by producing keratinocyte growth
factor, which causes epithelial cell proliferation and restoration
of barrier functions in the gut (144). Germ-free animals, even
though they have a similar numbers of γδ IELs as their conven-
tional counterparts, have significantly decreased ability to promote
mucosal injury repair and prevention of invasion by opportunis-
tic pathogens (143). This problem is evidenced by their decreased
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ability to produce antimicrobiotal peptides, such as RegIIIγ, as
well as pro-inflammatory chemokines and cytokines, such as IL-
1β, KC, and MIP2α (143), indicating that commensal microbes are
required to promote γδ IEL function.
Continued research will reveal the crosstalk between micro-
biota and these two populations of IELs as they directly relate to
intestinal homeostasis. IELs are able to produce both anti- and
pro-inflammatory cytokines and promote both strong cytotoxic
and tissue-repair responses.
SYSTEMIC T CELL RESPONSES TO INFECTION
Effects of gut microbiota on innate immune responses to systemic
viruses and bacteria have been well demonstrated in the literature
(108, 145–147). However, the mechanisms whereby microbiota
affects non-mucosal T cell responses have been difficult to compre-
hend as peripheral T cells are not in direct contact with commensal
bacteria. Because T cells confer long-term protection and mem-
ory against pathogens, understanding the role of microbiota on
T cell responses to infection is crucial. Studies from the 1970s
indicated that germ-free and conventional animals exhibit similar
immune responses to systemic infection by Salmonela paratyphi
or lymphocytic choriomeningitis virus (LCMV) (146).
A few groups infected germ-free mice with systemic pathogens
in the 1990s. Even though they compared mainly antibody produc-
tion to assess the immune responses in these mice, a speculation
can be made that antibody production is directly connected to
T cell responses as T cell help is required for class switching
and somatic hypermutation. One group, which infected mice
with MCMV and subsequently with Klebsiella pneumoniae, con-
cluded that germ-free mice were significantly more susceptible
to both pathogens and did not clear the infection in various
organs at the same rate as SPF counterparts (148). Moreover, they
showed increased mortality by bacterial infection (148). Histo-
logically, the spleens and livers of germ-free animals were more
severely affected by the infection and recovered more slowly (148).
Another group, which infected germ-free mice with Salmonella
typhimurium, showed that they were more susceptible to sys-
temic infection than conventional controls (149). Furthermore,
they noted a decrease in IgG and IgM responses in the germ-free
mice. It could be inferred that the inability to clear a viral and
intracellular bacterial infections as well as the decreased antibody
production is a result of an impaired T cell response in germ-free
mice. Indeed, with improved techniques, more recent work has
suggested that systemic immune responses are dampened in the
absence of commensal microbes.
Germ-free animals were found to have a higher susceptibility
to a prolonged and non-limiting Listeria monocytogenes infection
compared to conventional animals, a phenomenon supposedly
due to the inability of germ-free mice to accumulate T cells at
inflammation sites (145, 150). Although Listeria monocytogenes
is naturally an intestinal pathogen, the method utilized in these
studies resulted primarily in infection of the host spleen. Like-
wise,adaptive immune responses to viral infection of non-mucosal
sites are also shaped by the presence of commensal microbes.
Antibiotic-treated mice generate significantly fewer virus-specific
effector CD4 and CD8 T cells when compared to untreated con-
trols during influenza infection (151). Functionally, CD4 and
CD8 T cells in antibiotic-treated mice produce lower amounts
of pro-inflammatory cytokines, which correlates with increased
virus titers in these mice (151). Further investigation by Abt et al.
indicated that antibiotic-treated mice more readily succumbed
to influenza infection when compared to conventional counter-
parts (108). T cell responses in antibiotic-treated mice indicated
a decrease in CD8 virus-specific T cells, further confirming that
commensal microbiota modulates T cell responses to systemic
viral infection (108). The authors concluded that the higher sus-
ceptibility of antibiotic-treated mice to infection was due to an
inability of macrophages to respond to type-1 interferon and
limit viral replication. However, they did not expound upon the
relationship between the macrophage defect and the CD8 T cell
phenotype they observed. It could be inferred that commensal-
derived signals provide tonic signaling to innate immune cells,
which in turn, influence the ability of these cells to effectively acti-
vate naïve T cells and convert them to fully functional effectors. A
detailed understanding on the effect of commensal microbiota on
systemic T cell responses is yet to be provided.
CONCLUSION
Commensal microbiota plays a crucial role in the development,
homeostasis, and regulation of the immune system. With the
current rise of autoimmune and inflammatory diseases, the impor-
tance of inducing and maintaining tolerance to commensal bac-
teria is increasingly appreciated. As a constant source of foreign
antigens, microbiota plays a pivotal role in inducing tolerance to
beneficial bacteria as well as in maintaining the immune system
poised to defend the host against pathogens. Since the adap-
tive immune system is often implicated in microbiota-associated
inflammatory and autoimmune conditions, understanding its
relationship with commensals is crucial. Metaphorically speaking,
if the host immune system is a house, the commensal microbes may
be likened to the embers in a fireplace. At homeostasis, they remain
glowing, providing constant minimal heating for the house. How-
ever, when the house so requires, i.e., when an immune response
is necessary, they help create a powerful flame.
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